Literature DB >> 11530717

Respiratory biofeedback-assisted therapy in panic disorder.

A E Meuret1, F H Wilhelm, W T Roth.   

Abstract

The authors describe a new methodologically improved behavioral treatment for panic patients using respiratory biofeedback from a handheld capnometry device. The treatment rationale is based on the assumption that sustained hypocapnia resulting from hyperventilation is a key mechanism in the production and maintenance of panic. The brief 4-week biofeedback therapy is aimed at voluntarily increasing self-monitored end-tidal partial pressure of carbon dioxide (PCO2) and reducing respiratory rate and instability through breathing exercises in patients' environment. Preliminary results from 4 patients indicate that the therapy was successful in reducing panic symptoms and other psychological characteristics associated with panic disorder. Physiological data obtained from home training, 24-hour ambulatory monitoring pretherapy and posttherapy, and laboratory assessment at follow-up indicate that patients started out with low resting PCO2 levels, increased those levels during therapy, and maintained those levels at posttherapy and/or follow-up. Partial dissociation between PCO2 and respiratory rate questions whether respiratory rate should be the main focus of breathing training in panic disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530717     DOI: 10.1177/0145445501254006

Source DB:  PubMed          Journal:  Behav Modif        ISSN: 0145-4455


  14 in total

1.  Acute effects of device-guided slow breathing on sympathetic nerve activity and baroreflex sensitivity in posttraumatic stress disorder.

Authors:  Ida T Fonkoue; Paul J Marvar; Seth D Norrholm; Melanie L Kankam; Yunxiao Li; Dana DaCosta; Barbara O Rothbaum; Jeanie Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

2.  A wearable respiratory biofeedback system based on generalized body sensor network.

Authors:  Guan-Zheng Liu; Bang-Yu Huang; Lei Wang
Journal:  Telemed J E Health       Date:  2011-05-05       Impact factor: 3.536

3.  Ecological sounds affect breath duration more than artificial sounds.

Authors:  Mauro Murgia; Ilaria Santoro; Giorgia Tamburini; Valter Prpic; Fabrizio Sors; Alessandra Galmonte; Tiziano Agostini
Journal:  Psychol Res       Date:  2015-01-31

4.  Hypoventilation training for asthma: a case illustration.

Authors:  Ashton M Jeter; Hwacha C Kim; Erica Simon; Thomas Ritz; Alicia E Meuret
Journal:  Appl Psychophysiol Biofeedback       Date:  2012-03

Review 5.  Hyperventilation in panic disorder and asthma: empirical evidence and clinical strategies.

Authors:  Alicia E Meuret; Thomas Ritz
Journal:  Int J Psychophysiol       Date:  2010-05-25       Impact factor: 2.997

6.  Knowledge, attitudes, and practice behaviors (KAPb) of nurses and the effectiveness of a training program in psychosocial cancer care.

Authors:  Rathi Mahendran; Joanne Chua; Chao Xu Peh; Haikel A Lim; Emily N K Ang; Siew Eng Lim; Ee Heok Kua
Journal:  Support Care Cancer       Date:  2014-03-11       Impact factor: 3.603

7.  Reducing Test Anxiety and Related Symptoms Using a Biofeedback Respiratory Practice Device: A Randomized Control Trial.

Authors:  Amit Rosenberg; Daniel Hamiel
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-01-02

Review 8.  The integrative role of the sigh in psychology, physiology, pathology, and neurobiology.

Authors:  Jan-Marino Ramirez
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

9.  Further Exploration of Treatment Response in Latinos with Comorbid Asthma and Panic Disorder: A Brief Report of HRV and ETCO2 as Potential Mediators of Treatment Response.

Authors:  Krista L Nelson; Shou-En Lu; Tanya Oken; Paul M Lehrer; Jonathan M Feldman
Journal:  Appl Psychophysiol Biofeedback       Date:  2020-06

10.  Changes in respiration mediate changes in fear of bodily sensations in panic disorder.

Authors:  Alicia E Meuret; David Rosenfield; Stefan G Hofmann; Michael K Suvak; Walton T Roth
Journal:  J Psychiatr Res       Date:  2008-10-05       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.